1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors

Weitao Pan,Hua-Quan Miao,Yong-Jiang Xu,Elizabeth C Navarro,James R Tonra,Erik Corcoran,Armin Lahiji,Paul Kussie,Alexander S Kiselyov,Wai C Wong,Hu Liu
DOI: https://doi.org/10.1016/j.bmcl.2005.09.069
2006-01-15
Abstract:A novel class of 1-[4-(1H-benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-ureas are described as potent inhibitors of heparanase. Among them are 1,3-bis-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea (7a) and 1,3-bis-[4-(5,6-dimethyl-1H-benzoimidazol-2-yl)-phenyl]-urea (7d), which displayed good heparanase inhibitory activity (IC(50) 0.075-0.27 microM). Compound 7a showed good efficacy in a B16 metastasis model.
What problem does this paper attempt to address?